57. Linda Tempelman, CEO of Persista Bio on eradicating Type 1 Diabetes Artwork

Curiosity with Kristen

Here you’ll hear real conversations with every day people making a difference, living their purpose, being parents, trying their best and sharing their knowledge of life experiences, both professionally and personally. You’ll also hear from executives about their companies and what cool things they are doing plus how they are navigating their companies and people forward. Each episode is unique and covers wide ranging topics that give my guests an opportunity to share what they have learned, are learning and continuing to learn. Along with their wisdom, hope and some great stories too!

All Episodes

Curiosity with Kristen

57. Linda Tempelman, CEO of Persista Bio on eradicating Type 1 Diabetes

January 18, 2025 • Kristen Revell

Today I have Linda Tempelman, CEO of Persista Bio. With a PhD in Chemical Engineering from Cornell University and extensive experience in the biotech sector, Dr. Tempelman leads a team that’s breaking through barriers in cell therapy.

Persista Bio’s pioneering O2Line™ system is designed to overcome immune rejection and support the long-term viability of therapeutic cells. Focused on enabling advanced treatments for chronic conditions like Type 1 Diabetes, their work has the potential to replace traditional therapies and pave the way for a new era of patient care. This could also eradicate diabetes!

Join us as we explore Dr. Tempelman’s journey, the innovative work of Persista Bio, and the transformative impact their technology could have on healthcare.

www.linkedin.com/in/ltempelman/
www.persistabio.com

Find me on LinkedIn @ www.linkedin.com/in/krev/
www.therevellgroup.com